In terms of performance, CSF YKL-40 has moderate sensitivity for MS disease activity (it may not rise during every relapse but tends to be higher in patients with a more aggressive disease course) and moderate specificity (it is also elevated in other neurological conditions involving neuroinflammation, such as CNS infections or neurodegenerative diseases) [14]. Here, CHI3L1 is linked to myeloid sarcoma.